These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3563982)

  • 1. DDAVP-induced correction of prolonged bleeding time in patients with congenital platelet function defects.
    Schulman S; Johnsson H; Egberg N; Blombäck M
    Thromb Res; 1987 Jan; 45(2):165-74. PubMed ID: 3563982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of DDAVP in inherited and acquired platelet dysfunction.
    DiMichele DM; Hathaway WE
    Am J Hematol; 1990 Jan; 33(1):39-45. PubMed ID: 2293761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet aggregation at high shear is impaired in patients with congenital defects of platelet secretion and is corrected by DDAVP: correlation with the bleeding time.
    Cattaneo M; Pareti FI; Zighetti M; Lecchi A; Lombardi R; Mannucci PM
    J Lab Clin Med; 1995 Apr; 125(4):540-7. PubMed ID: 7706911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1-Desamino-8-D-arginine vasopressin (DDAVP) infusion in type IIB von Willebrand's disease: shortening of bleeding time and induction of a variable pseudothrombocytopenia.
    Casonato A; Sartori MT; de Marco L; Girolami A
    Thromb Haemost; 1990 Aug; 64(1):117-20. PubMed ID: 2274916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DDAVP normalized the bleeding time in patients with congenital platelet TxA2 receptor abnormality.
    Fuse I; Higuchi W; Mito M; Aizawa Y
    Transfusion; 2003 May; 43(5):563-7. PubMed ID: 12702175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience of desmopressin (DDAVP) administration in patients with congenital and acquired bleeding disorders.
    Tsay W; Shen MC
    J Formos Med Assoc; 1992 Oct; 91(10):962-9. PubMed ID: 1362675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidural analgesia in a preeclamptic parturient after normalization of a prolonged bleeding time with DDAVP.
    Fragneto RY; Datta S
    Reg Anesth; 1995; 20(5):448-51. PubMed ID: 8519724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shortening of bleeding time by 1-deamino-8-D-arginine vasopressin in various bleeding disorders.
    Kobrinsky NL; Israels ED; Gerrard JM; Cheang MS; Watson CM; Bishop AJ; Schroeder ML
    Lancet; 1984 May; 1(8387):1145-8. PubMed ID: 6144876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shortening of bleeding time by 1-deamino-8-arginine vasopressin (DDAVP) in the absence of platelet von Willebrand factor in Gray platelet syndrome.
    Pfueller SL; Howard MA; White JG; Menon C; Berry EW
    Thromb Haemost; 1987 Dec; 58(4):1060-3. PubMed ID: 3502198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of DDAVP administrated subcutaneously in dogs with aspirin-induced platelet dysfunction and hemostatic impairment due to chronic liver diseases.
    Sakai M; Watari T; Miura T; Maruyama H; Koie H; Yamaya Y; Takeuchi A; Hasegawa A
    J Vet Med Sci; 2003 Jan; 65(1):83-6. PubMed ID: 12576709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of von Willebrand's disease.
    Mannucci PM
    J Intern Med Suppl; 1997; 740():129-32. PubMed ID: 9350194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desmopressin in inherited disorders of platelet function.
    Coppola A; Di Minno G
    Haemophilia; 2008 Jan; 14 Suppl 1():31-9. PubMed ID: 18173692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of desmopressin in children with coagulation disorders.
    Brown OE
    Int J Pediatr Otorhinolaryngol; 1986 Sep; 11(3):301-5. PubMed ID: 3771110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of patients with bleeding disorder to DDAVP administration.
    Chuansumrit A; Hathirat P; Pintadit P; Isarangkura P
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():174-9. PubMed ID: 7886567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of von Willebrand's Disease.
    Mannucci PM
    N Engl J Med; 2004 Aug; 351(7):683-94. PubMed ID: 15306670
    [No Abstract]   [Full Text] [Related]  

  • 16. A systematic review: The use of desmopressin for treatment and prophylaxis of bleeding disorders in pregnancy.
    Trigg DE; Stergiotou I; Peitsidis P; Kadir RA
    Haemophilia; 2012 Jan; 18(1):25-33. PubMed ID: 21624012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of ADP in platelet aggregation at high shear: studies in a patient with congenital defect of platelet responses to ADP.
    Cattaneo M; Zighetti ML; Lombardi R; Mannucci PM
    Br J Haematol; 1994 Dec; 88(4):826-9. PubMed ID: 7819105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease.
    Holmberg L; Nilsson IM; Borge L; Gunnarsson M; Sjörin E
    N Engl J Med; 1983 Oct; 309(14):816-21. PubMed ID: 6412139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desmopressin: therapeutic limitations in children and adults with inherited coagulation disorders.
    Nolan B; White B; Smith J; O'Reily C; Fitzpatrick B; Smith OP
    Br J Haematol; 2000 Jun; 109(4):865-9. PubMed ID: 10929043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inherited Bleeding Disorders in the Obstetric Patient.
    Bannow BS; Konkle BA
    Transfus Med Rev; 2018 Oct; 32(4):237-243. PubMed ID: 30097224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.